Skip to main content

Nonprofit · EIN 23-7373091

AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES

Tax-exempt · ALEXANDRIA, VA 22314

Financials

$16.1M$19M2022$15.9M$18.6M2023$18.3M$20.3M2024
Revenue Expenses · by fiscal year end
Financials of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
June 30, 2025990$18,281,444$20,311,953-$2,030,509$35,063,665$6,901,088$28,162,577
June 30, 2024990$15,925,326$18,577,313-$2,651,987$34,244,566$5,730,045$28,514,521
June 30, 2023990$16,078,688$19,046,321-$2,967,633$34,254,767$5,246,696$29,008,071
Financial details: 990 for the year ended June 30, 2025

Revenue

Contributions, gifts and grants
$3,492,285
Program service revenue
$11,990,006
Investment income
$875,677
Royalties
$1,581,857
Net gain from sales of assets
$179,268
Other revenue
$1,923,476

Expenses

Grants and similar amounts paid
$1,322,897
Compensation of officers, directors and key employees
$1,361,111
Other salaries and wages
$3,799,176
Salaries, compensation and benefits (total)
$6,427,212
Professional fundraising fees
$0
Legal fees
$26,062
Accounting fees
$54,896
Occupancy
$714,001
Travel
$854,577
Depreciation
$33,760
Program services (functional)
$17,813,951
Management and general (functional)
$2,478,659
Fundraising (functional)
$19,343

Balance sheet and other

Total assets, start of year
$34,244,566
Total assets, end of year
$35,063,665
Total liabilities, end of year
$6,901,088
Net assets, end of year
$28,162,577
Land, buildings and equipment
$4,227,194
Publicly traded securities
$23,520,345
Net assets without donor restrictions
$22,819,723
Net assets with donor restrictions
$5,342,854
Gross unrelated business income
$47,903
Gross receipts
$28,968,064
Employees
49
Volunteers
301
Year formed
1950
State of legal domicile
IL

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended June 30, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
MATTHEW D'UVACHIEF EXECUTIVE OFFICER
Officer
43$637,833$109,073
JULIE DEAL END 013125AASLD DEP. EXEC. DIR./FDN
Officer
21$287,813$20,815
MARJORIE BYNUMCHIEF OF STAFF
Key employee
39$254,953$38,363
JESSICA CURTISVP, MEETINGS AND CORP. PAR
Highest-paid employee
39$244,693$39,774
ELIZABETH DURZYVP, PUBL. AND PRACTICE RESOURCES
Highest-paid employee
39$212,074$33,650
MUKARAB ISLAMVP, FINANCE AND ADMINISTRATION
Officer
39$196,100$36,139
STEVEN FOLSTEINVP OF EDUCATION AND PROF DVLPMNT
Highest-paid employee
43$168,463$32,623
CRYSTAL JONESDIRECTOR, HUMAN RESOURCES
Highest-paid employee
35$142,287$29,736
LAURA SHELTERSDIRECTOR, EDU., PROGRAM DESIGN, & EVALUATION
Highest-paid employee
35$142,750$26,956
GRACE L SUPRESIDENT
Trustee or director, Officer
5$75,000$0
TAMAR TADDEITREASURER
Trustee or director, Officer
5$30,000$0
SAUL J KARPENPRESIDENT-ELECT
Trustee or director, Officer
5$0$0
W RAY KIMPAST PRESIDENT
Trustee or director, Officer
5$0$0
JANICE JOUSECRETARY
Trustee or director, Officer
5$0$0
MICHAEL R LUCEYSR. COUNCILOR
Trustee or director
5$0$0
5 more people on this return
NameTitleHours / weekCompensation
NANCY REAUCOUNCILOR
Trustee or director
5$0
ROTONYA MCCANTS CARRCOUNCILOR
Trustee or director
5$0
OREN FIXCOUNCILOR AT LARGE
Trustee or director
5$0
ANJI WALLCOUNCILOR AT LARGE
Trustee or director
5$0
HARMET MALHICOUNCILOR AT LARGE
Trustee or director
5$0
990 for the year ended June 30, 2024: 22 people
NameTitleHours / weekCompensationOther / benefits
MATTHEW D'UVACHIEF EXECUTIVE OFFICER
Officer
38$611,896$89,035
JULIE DEALAASLD DEP. EXEC. DIR./FDN EXEC. DIR.
Officer
30$289,397$48,919
MARJORIE BYNUMCHIEF OF STAFF
Key employee
35$244,201$34,567
JESSICA CURTISVP, MEETINGS AND CORP. PARTNERSHIPS
Highest-paid employee
35$207,816$34,610
CAROLINE LAURENVP, MARKETING AND MEMBERSHIP
Highest-paid employee
35$200,978$34,481
ELIZABETH DURZYVP, PUBL. AND PRACTICE RESOURCES
Highest-paid employee
35$202,138$30,471
MUKARAB ISLAMVP, FINANCE AND ADMINISTRATION
Officer
37.6$189,428$33,535
CRYSTAL JONESDIRECTOR, HUMAN RESOURCES
Highest-paid employee
35$141,946$27,990
AUDREY DAVIS-OWINOSR. DIR., CLIN. GUIDELINES & QUALITY
Highest-paid employee
35$142,886$23,252
NORAH TERRAULT PRESIDENT(UNTIL 01/2024), PAST PRESIDENT
Trustee or director, Officer
5$50,000$0
W RAY KIM PRESIDENT-ELECT(UNTIL 01/2024), PRESIDENT
Trustee or director, Officer
5$25,000$0
HARMET MALHICOUNCILOR AT LARGE
Trustee or director
5$18,000$0
TAMAR TADDEITREASURER
Trustee or director, Officer
5$15,000$0
CARLA W BRADYSECRETARY
Trustee or director, Officer
5$15,000$0
LAURIE DELEVEPAST PRESIDENT (UNTIL 12/2023)
Trustee or director, Officer
5$0$0
GRACE L SU COUNCILOR(UNTIL 01/2024), PRESIDENT-ELECT
Trustee or director, Officer
5$0$0
OREN FIXCOUNCILOR AT LARGE
Trustee or director
5$0$0
SAUL J KARPENCOUNCILOR
Trustee or director
5$0$0
MICHAEL R LUCEYCOUNCILOR
Trustee or director
5$0$0
PAUL MARTINCOUNCILOR AT LARGE (UNTIL 12/2023)
Trustee or director
5$0$0
ROTONYA MCCANTS CARRCOUNCILOR
Trustee or director
5$0$0
KIM M OLTHOFFCOUNCILOR AT LARGE
Trustee or director
5$0$0
990 for the year ended June 30, 2023: 19 people
NameTitleHours / weekCompensationOther / benefits
MATTHEW D'UVACHIEF EXECUTIVE OFFICER
Officer
44$548,225$80,004
JULIE DEALAASLD DEPUTY EXEC. DIR./FDN ED
Officer
31$258,283$45,598
MARJORIE BYNUMCHIEF OF STAFF
Highest-paid employee
38$219,074$31,762
ELIZABETH DURZYVP, PUBLICATIONS & PRACTICE RESOURCES
Highest-paid employee
35$180,415$27,799
CAROLINE LAURENVP, MARKETING AND MEMBERSHIP
Highest-paid employee
35$175,752$32,405
MUKARAB ISLAMVP, FINANCE & ADMINISTRATION
Officer
36$173,406$31,339
JESSICA CURTISVP, MEETINGS & CORPORATE PARTNERSHIPS
Highest-paid employee
35$147,849$31,073
AUDREY DAVIS-OWINOSR. DIR., CLIN. GUIDELINES & QUALITY
Highest-paid employee
35$134,249$22,760
LAURIE D DELEVEPAST PRESIDENT
Trustee or director, Officer
5$50,000$0
CARLA W BRADYSECRETARY
Trustee or director, Officer
5$15,000$0
NORAH TERRAULTPRESIDENT
Trustee or director, Officer
5$0$0
W RAY KIMPRESIDENT-ELECT
Trustee or director, Officer
5$0$0
TAMAR TADDEITREASURER
Trustee or director, Officer
5$0$0
MICHAEL R LUCEYCOUNCILOR
Trustee or director
5$0$0
GRACE L SUCOUNCILOR
Trustee or director
5$0$0
SAUL J KARPENCOUNCILOR
Trustee or director
5$0$0
OREN FIXCOUNCILOR AT LARGE
Trustee or director
5$0$0
PAUL MARTINCOUNCILOR AT LARGE
Trustee or director
5$0$0
KIM M OLTHOFFCOUNCILOR AT LARGE
Trustee or director
5$0$0

Address and contacts

Address (IRS master file)
1001 N FAIRFAX ST STE 400, ALEXANDRIA, VA 22314-1587
Principal officer (990 for 2024)
GRACE L SU, 1001 NORTH FAIRFAX STREET 400, ALEXANDRIA, VA 223141587
Signed the 990
MATTHEW R D'UVA, CEO
Phone
(703) 299-9766
Return prepared by
GELMAN ROSENBERG & FREEDMAN

Mission

TO ADVANCE AND DISSEMINATE THE SCIENCE AND PRACTICE OF HEPATOLOGY, AND TO PROMOTE LIVER HEALTH AND QUALITY PATIENT CARE.

990 for the year ended June 30, 2025

Program accomplishments

  • MEETINGS AND EDUCATION, INCLUDING THE LIVER MEETING: AASLD'S DYNAMIC EDUCATIONAL PROGRAMS PROVIDE HEALTHCARE PROFESSIONALS CUTTING-EDGE ADVANCEMENTS IN SCIENCE AND INNOVATIVE NEW TECHNIQUES TO ADVANCE HEPATOLOGY TRAINING AND PROFESSIONAL DEVELOPMENT THROUGH IMMERSIVE FACE-TO-FACE EVENTS AND ROBUST ONLINE LEARNING PLATFORMS. THESE INITIATIVES FOSTER THE EXCHANGE OF GROUNDBREAKING RESEARCH, ELEVATE PATIENT CARE, AND SPARK NEW DISCOVERIES IN LIVER DISEASE MANAGEMENT. THE LIVER MEETING, AASLD'S PREMIER ANNUAL EVENT, IS A GLOBAL CORNERSTONE FOR THE FIELD OF HEPATOLOGY, SHOWCASING TRANSFORMATIVE RESEARCH AND TREATMENT OUTCOMES. ATTENDEES ENGAGE IN PLENARY AND PARALLEL SESSIONS, POSTER PRESENTATIONS, STATE-OF-THE-ART LECTURES, MEET-THE-EXPERT SESSIONS, SPECIALTY COURSES, AND SPECIAL INTEREST GROUP PROGRAMMING FOSTERING COLLABORATION AND KNOWLEDGE-SHARING AMONG LEADING EXPERTS AND PRACTITIONERS. ADDITIONALLY, AASLD HOSTS FOCUSED STAND-ALONE EVENTS LIKE THE EMERGING TOPIC CONFERENCES, CO-SPONSORS DIGESTIVE DISEASE WEEK, AND PARTNERS WITH DOMESTIC AND INTERNATIONAL MEDICAL SOCIETIES, GOVERNMENT ENTITIES, AND NONPROFIT ORGANIZATIONS TO DELIVER IMPACTFUL EDUCATIONAL PROGRAMMING IN HEPATOLOGY.AASLD'S ONLINE LEARNING ECOSYSTEM, ANCHORED BY LIVERLEARNING, THE OFFICIAL E-LEARNING PORTAL, OFFERS ON-DEMAND WEBINARS ORGANIZED BY SPECIAL INTEREST GROUPS, PROVIDING IN-DEPTH EXPLORATION OF SPECIALIZED TOPICS. LIVERLEARNING SERVES AS A COMPREHENSIVE DIGITAL REPOSITORY, HOUSING CONTENT FROM AASLD MEETINGS, PRACTICE GUIDELINES, SLIDE COMPILATIONS, AND COURSE HANDOUTS, ENABLING HEALTHCARE PROVIDERS TO SEAMLESSLY APPLY THE LATEST MEDICAL KNOWLEDGE TO CLINICAL PRACTICE. THE ORGANIZATION ALSO SUPPORTS ONLINE CONTENT THROUGH SIGNAL PLATFORM SPECIFICALLY DESIGNED FOR OUR SPECIAL INTEREST GROUPS. AASLD IS ACCREDITED BY THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION (ACCME) TO PROVIDE AMA PRA CATEGORY 1 CREDITS FOR PHYSICIANS. ADDITIONALLY, AASLD OFFERS MAINTENANCE OF CERTIFICATION (MOC) POINTS, AWARDED UPON SUCCESSFUL COMPLETION OF DESIGNATED CME PROGRAMS, WITH MOC ULTIMATELY GRANTED BY THE AMERICAN BOARD OF INTERNAL MEDICINE OR AMERICAN BOARD OF PEDIATRICS.
    Expenses $9,743,304 · grants $4,500 · revenue $8,794,501
  • PUBLICATIONS: AASLD'S JOURNALS, HEPATOLOGY, LIVER TRANSPLANTATION, AND HEPATOLOGY COMMUNICATIONS DELIVER PEER-REVIEWED, HIGH-IMPACT RESEARCH ON LIVER AND BILIARY TRACT DISEASES, SETTING THE STANDARD FOR SCIENTIFIC EXCELLENCE IN THE FIELD. AASLD'S FLAGSHIP JOURNAL, HEPATOLOGY, PUBLISHES ORIGINAL, PEER-REVIEWED ARTICLES CONCERNING ALL ASPECTS OF LIVER STRUCTURE, FUNCTION AND DISEASE. EACH MONTH, THE DISTINGUISHED EDITORIAL BOARD MONITORS AND SELECTS ONLY THE BEST ARTICLES ON SUBJECTS SUCH AS IMMUNOLOGY, CHRONIC HEPATITIS, VIRAL HEPATITIS, CIRRHOSIS, GENETIC AND METABOLIC LIVER DISEASES AND THEIR COMPLICATIONS, LIVER CANCER, AND DRUG METABOLISM. LIVER TRANSPLANTATION PUBLISHES CUTTING EDGE SCIENTIFIC BREAKTRLIVER TRANSPLANTATION, A SPECIALIZED JOURNAL, PROVIDES AUTHORITATIVE INSIGHTS INTO THE LATEST ADVANCEMENTS IN LIVER TRANSPLANTATION. HEPATOLOGY COMMUNICATIONS, AN OPEN-ACCESS, PEER-REVIEWED JOURNAL, ENSURES RAPID DISSEMINATION OF HIGH-QUALITY BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH, AMPLIFYING AASLD'S COMMITMENT TO ADVANCING HEPATOLOGY WORLDWIDE.PROFESSIONAL RELATIONS: AASLD'S PROFESSIONAL RELATIONS INITIATIVES STRENGTHEN THE HEPATOLOGY COMMUNITY THROUGH:1. AASLD PRACTICE GUIDELINES: EVIDENCE-BASED RECOMMENDATIONS GROUNDED IN RIGOROUS SCIENTIFIC RESEARCH TO GUIDE PRACTITIONERS AND PATIENTS IN MAKING INFORMED HEALTHCARE DECISIONS FOR SPECIFIC CLINICAL SCENARIOS.2. PRACTICE METRICS COMMITTEE: THIS COMMITTEE DEVELOPS AND REFINES PERFORMANCE MEASURES TO EVALUATE AND ENHANCE THE QUALITY OF CARE FOR LIVER DISEASE PATIENTS FROM BOTH PROVIDER AND PATIENT PERSPECTIVES. IT DRIVES QUALITY IMPROVEMENT INITIATIVES, SUCH AS THE CIRRHOSIS QUALITY COLLABORATIVE (CQC), AND COLLABORATES WITH OTHER AASLD COMMITTEES AND SPECIALTY SOCIETIES TO ADVANCE PATIENT SAFETY AND CARE STANDARDS.3. RELATED SOCIETY COLLABORATIONS: AASLD FOSTERS PARTNERSHIPS WITH DOMESTIC AND INTERNATIONAL MEDICAL SOCIETIES TO ADVANCE HEPATOLOGY THROUGH SHARED PROGRAMS AND ACTIVITIES. MEMBER REPRESENTATIVES ADVOCATE FOR AASLD'S MISSION AT GLOBAL MEETINGS, CREATING PROGRAMS THAT RESONATE WITH AUDIENCES INTERESTED IN MUTUAL TOPICS.4. PATIENT ENGAGEMENT: AASLD IS DEDICATED TO DEEPENING PATIENT CONNECTIONS BY INCREASING PATIENT REPRESENTATION IN ITS ACTIVITIES, ENHANCING ACCESS TO EXPERT RESOURCES, AND BUILDING ROBUST ADVOCACY PARTNERSHIPS TO AMPLIFY THE PATIENT VOICE IN HEPATOLOGY.CLINICAL AND PUBLIC POLICY: AASLD'S PUBLIC POLICY COMMITTEE LEADS A ROBUST ADVOCACY PROGRAM, HOSTING TWO KEY ANNUAL EVENTS: - LIVER CAPITOL HILL DAY: IN PARTNERSHIP WITH PATIENT ADVOCACY ORGANIZATIONS, AASLD EDUCATES CONGRESSIONAL LEGISLATORS AND STAFF ON CRITICAL ISSUES IN LIVER DISEASE RESEARCH AND PATIENT CARE, DRIVING POLICY CHANGE.- FEDERAL AGENCY DAY: AASLD ENGAGES WITH FEDERAL AGENCY PARTNERS TO ALIGN THE SCIENTIFIC COMMUNITY WITH FEDERAL RESEARCH PRIORITIES, FOSTERING COLLABORATION AND INNOVATION.AASLD ENSURES ITS MEMBERS STAY INFORMED ON LEGISLATIVE AND AGENCY DECISIONS IMPACTING HEPATOLOGY, ENCOURAGING ACTIVE PARTICIPATION IN PUBLIC POLICY ADVOCACY.
    Expenses $5,929,583 · grants $1,208,397 · revenue $1,279,000
  • MEMBERSHIP & MENTORSHIP: AASLD'S VIBRANT MEMBERSHIP OF OVER 7,000 PROFESSIONALSSPANNING PHYSICIANS, SCIENTISTS, HEPATOLOGISTS, SURGEONS, PATHOLOGISTS, STUDENTS, AND ALLIED HEALTH EXPERTSDRIVES HEPATOBILIARY RESEARCH AND PATIENT CARE WORLDWIDE. THE AASLD MENTORSHIP PROGRAM INSPIRES AND NURTURES THE NEXT GENERATION OF HEPATOLOGISTS BY PAIRING MEDICAL, SURGICAL, AND PEDIATRIC RESIDENTS, FELLOWS, AND EARLY-CAREER PROFESSIONALS WITH SEASONED MENTORS. THIS PROGRAM ENSURES A LEGACY OF SKILLED, KNOWLEDGEABLE HEPATOLOGISTS DEDICATED TO ACADEMIC MEDICINE AND PATIENT CARE.WEBSITE: AASLD'S WEBSITES (WWW.AASLD.ORG AND HCVGUIDELINES.ORG) SERVE AS A VITAL HUB FOR MEMBERS, SCIENTISTS, PHYSICIANS, ALLIED HEALTH PROFESSIONALS, AND THE PUBLIC, OFFERING SEAMLESS ACCESS TO CUTTING-EDGE HEPATOLOGY RESOURCES. WITH OVER 2.1 MILLION ANNUAL VISITORS, THE SITE FACILITATES EXPLORATION OF RESEARCH, EDUCATIONAL OFFERINGS, AND PROFESSIONAL OPPORTUNITIES IN HEPATOLOGY.COMMUNICATIONSAASLD KEEPS ITS COMMUNITY INFORMED THROUGH THE BIWEEKLY AASLD E-NEWS, DELIVERING UPDATES ON RESEARCH, MILESTONES, AND POLICY DEVELOPMENTS TO MEMBERS. THE ASSOCIATION ALSO AMPLIFIES ITS IMPACT THROUGH STRATEGIC MEDIA RELATIONS, SPOTLIGHTING GROUNDBREAKING RESEARCH FROM THE LIVER MEETING AND ADVOCATING FOR ADVANCES IN LIVER DISEASE TREATMENT AND PATIENT CARE.
    Expenses $2,141,064 · grants $110,000 · revenue $1,916,505

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025June 30, 2026November 16, 2026Not due yet
2024June 30, 2025November 17, 2025990 on file
2023June 30, 2024November 15, 2024990 on file

IRS record

EIN
23-7373091
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1975
Accounting year ends
June
Files
Form 990 or 990-EZ
Assets (IRS master file)
$35,063,665
Income (IRS master file)
$28,968,064

Filing history

FormYear endedRevenueExpensesAssetsReturn
990June 2025$18,281,444$20,311,953$35,063,665XML
990-TJune 2025–––IRS
990June 2024$15,925,326$18,577,313$34,244,566XML
990-TJune 2024–––IRS
990June 2023$16,078,688$19,046,321$34,254,767XML
990-TJune 2023–––IRS
990June 2022$8,439,460$15,175,180$35,081,762IRS
990-TJune 2022–––IRS
990June 2021–––IRS
990-TJune 2021–––IRS
990June 2020–––IRS
990June 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 23-7373091).

Questions about AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES

What is the EIN of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES?
The employer identification number (EIN) of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES is 23-7373091.
Is AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1975.
Are donations to AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES due?
The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended June 2025.
Who is the principal officer of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES?
The 990 for the year ended June 30, 2025 names GRACE L SU.
Who are the officers and directors of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES?
The 990 for the year ended June 30, 2025 lists 20 people; 11 received compensation from the organization, the highest $637,833 (MATTHEW D'UVA, CHIEF EXECUTIVE OFFICER).
How much revenue does AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES have?
On its 990 for the year ended June 30, 2025 it reported revenue of $18,281,444, expenses of $20,311,953 and total assets of $35,063,665 at year end.

Other nonprofits in ALEXANDRIA

All nonprofits in ALEXANDRIA · Virginia · Voluntary health associations and medical disciplines